Want to join the conversation?
$STJ said that for FY16 the company continues to expect gross profit margin to be in the range of 69-69.5%, which includes the expectation of continued weakness in the US CRM business. R&D expenses in 1Q16 were 13% of net sales and for FY16 $STJ expects R&D expense to be in the range of 12.5-13% of net sales.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?